ClinicalTrialsFinder

PD-1 Antibody Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC

EGFR Activating MutationLung Cancer Non-Small Cell Cancer (NSCLC)PD-1 Antibody
Nanfang Hospital, Southern Medical University32 enrolled1 locationNCT07637448